Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Return on Assets (2016 - 2025)

Lipocine's Return on Assets history spans 13 years, with the latest figure at 0.32% for Q3 2025.

  • For Q3 2025, Return on Assets fell 13.0% year-over-year to 0.32%; the TTM value through Sep 2025 reached 0.32%, down 13.0%, while the annual FY2024 figure was 0.0%, 54.0% up from the prior year.
  • Return on Assets reached 0.32% in Q3 2025 per LPCN's latest filing, down from 0.23% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.1% in Q3 2022 to a low of 0.68% in Q4 2023.
  • Average Return on Assets over 5 years is 0.27%, with a median of 0.31% recorded in 2023.
  • Peak YoY movement for Return on Assets: surged 82bps in 2021, then crashed -69bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.01% in 2021, then plummeted by -1946bps to 0.28% in 2022, then plummeted by -145bps to 0.68% in 2023, then skyrocketed by 100bps to 0.0% in 2024, then plummeted by -81848bps to 0.32% in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Return on Assets are 0.32% (Q3 2025), 0.23% (Q2 2025), and 0.25% (Q1 2025).